Mark S. Silverberg

46.7k total citations · 2 hit papers
249 papers, 8.7k citations indexed

About

Mark S. Silverberg is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Mark S. Silverberg has authored 249 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Genetics, 131 papers in Epidemiology and 100 papers in Surgery. Recurrent topics in Mark S. Silverberg's work include Inflammatory Bowel Disease (192 papers), Microscopic Colitis (116 papers) and Helicobacter pylori-related gastroenterology studies (46 papers). Mark S. Silverberg is often cited by papers focused on Inflammatory Bowel Disease (192 papers), Microscopic Colitis (116 papers) and Helicobacter pylori-related gastroenterology studies (46 papers). Mark S. Silverberg collaborates with scholars based in Canada, United States and Israel. Mark S. Silverberg's co-authors include A. Hillary Steinhart, Gordon R. Greenberg, Anne M. Griffiths, Joanne M. Stempak, Renata Villela, Elana Maser, Cynthia H. Seow, Kenneth Croitoru, Boyko Kabakchiev and Raquel Milgrom and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Mark S. Silverberg

239 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease

2006 511 citations Mark S. Silverberg, Gordon R. Greenberg et al. profile →
Association of host genome with intestinal microbial composition in a large healthy cohort

2016 322 citations Williams Turpin, Wei Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Silverberg Canada	51	5.6k	3.8k	2.3k	2.0k	2.0k	249	8.7k
Iris Dotan Israel	49	5.0k 0.9×	4.2k 1.1×	2.0k 0.9×	2.4k 1.2×	1.9k 0.9×	320	9.5k
William A. Faubion United States	46	4.1k 0.7×	3.3k 0.9×	2.6k 1.1×	2.4k 1.2×	1.4k 0.7×	195	8.9k
Subra Kugathasan United States	47	5.1k 0.9×	3.4k 0.9×	1.7k 0.8×	2.2k 1.1×	1.2k 0.6×	175	7.8k
Miquel A. Gassull Spain	35	3.8k 0.7×	3.2k 0.8×	2.4k 1.1×	2.1k 1.0×	1.7k 0.9×	81	8.3k
Walter Reinisch Austria	41	5.6k 1.0×	4.1k 1.1×	2.0k 0.9×	2.0k 1.0×	1.1k 0.5×	223	8.1k
Alessandro Armuzzi Italy	52	5.8k 1.0×	4.4k 1.2×	2.1k 0.9×	3.5k 1.7×	1.5k 0.7×	435	10.4k
Torsten Kucharzik Germany	50	3.7k 0.7×	2.6k 0.7×	2.6k 1.2×	2.5k 1.2×	1.8k 0.9×	198	9.2k
Konstantinos A. Papadakis United States	44	3.8k 0.7×	2.5k 0.7×	2.5k 1.1×	1.5k 0.7×	1.3k 0.7×	95	7.1k
Fernando Magro Portugal	41	5.5k 1.0×	4.2k 1.1×	1.5k 0.6×	2.4k 1.2×	1.1k 0.5×	307	8.6k
Frank M. Ruemmele France	49	5.1k 0.9×	3.3k 0.9×	2.2k 1.0×	3.5k 1.7×	1.0k 0.5×	156	9.9k

Countries citing papers authored by Mark S. Silverberg

Since Specialization

Citations

This map shows the geographic impact of Mark S. Silverberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Silverberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Silverberg more than expected).

Fields of papers citing papers by Mark S. Silverberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Silverberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Silverberg. The network helps show where Mark S. Silverberg may publish in the future.

Co-authorship network of co-authors of Mark S. Silverberg

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Silverberg. A scholar is included among the top collaborators of Mark S. Silverberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Silverberg. Mark S. Silverberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olivera, Pablo A., Cristian Hernández-Rocha, Williams Turpin, et al.. (2025). Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn’s Disease Following Ileocolic Resection. Inflammatory Bowel Diseases. 31(12). 3247–3255. 1 indexed citations

Solitano, Virginia, Ropo Ebenezer Ogunsakin, Yuhong Yuan, et al.. (2025). Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study. The American Journal of Gastroenterology. 121(2). 410–423. 1 indexed citations

Olivera, Pablo A., Ji-Eun Kim, Geoffrey C. Nguyen, et al.. (2025). P1101 Real-world effectiveness and safety of Risankizumab in Crohn’s Disease. Journal of Crohn s and Colitis. 19(Supplement_1). i2023–i2024. 1 indexed citations

Leibovitzh, Haim, Shadi Nayeri, Cristian Hernández-Rocha, et al.. (2024). Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile. Journal of Crohn s and Colitis. 18(12). 1957–1966. 10 indexed citations

Hammoudi, Nassim, Matthieu Allez, Mark S. Silverberg, et al.. (2024). Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 60(3). 310–326. 2 indexed citations

Medina, Tiago da Silva, Alex Murison, Michelle I. Smith, et al.. (2023). The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population. Frontiers in Immunology. 14. 1161901–1161901. 7 indexed citations

Jairath, Vipul, Brian G. Feagan, Mark S. Silverberg, et al.. (2023). Sa1151 MUCOSAL HEALING WITH VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CHRONIC POUCHITIS: EVIDENCE FROM EARNEST, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Gastroenterology. 164(6). S–303. 1 indexed citations

Olivera, Pablo A. & Mark S. Silverberg. (2023). Biomarkers That Predict Crohn’s Disease Outcomes. Journal of the Canadian Association of Gastroenterology. 7(1). 59–67. 3 indexed citations

Croitoru, David, et al.. (2022). Clinical Features and Treatment Outcomes in Hidradenitis Suppurativa With Fistulizing Crohn’s Disease: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 26(4). 426–427.

10.

Battat, Robert, David Hudesman, Douglas C. Wolf, et al.. (2021). Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index. Crohn s & Colitis 360. 3(3). otab032–otab032. 5 indexed citations

11.

Nayeri, Shadi, Jiayi Ji, Cristian Hernández-Rocha, et al.. (2021). A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn’s Disease Recurrence. Journal of Crohn s and Colitis. 16(6). 900–910. 15 indexed citations

12.

Li, Dalin, Mark S. Silverberg, Talin Haritunians, et al.. (2016). TNFRSF1B Is Associated with ANCA in IBD. Inflammatory Bowel Diseases. 22(6). 1346–1352. 7 indexed citations

13.

Zanello, Galliano, David Kevans, Ashleigh Goethel, et al.. (2014). Genetics and Innate and Adaptive Immunity in IBD. Nestlé Nutrition Institute Workshop series. 79. 41–55. 18 indexed citations

14.

Gathungu, Grace, Mi‐Ok Kim, John Ferguson, et al.. (2013). Granulocyte–Macrophage Colony-Stimulating Factor Autoantibodies. Inflammatory Bowel Diseases. 19(8). 1671–1680. 59 indexed citations

15.

Waterman, Matti, Wei Xu, Amreen Dinani, et al.. (2012). Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut. 62(3). 387–394. 93 indexed citations

16.

Tyler, Andrea D., Raquel Milgrom, Joanne M. Stempak, et al.. (2012). The NOD2 insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. Gut. 62(10). 1433–1439. 71 indexed citations

17.

Reinisch, Walter, Gert Van Assche, Ragnar Befrits, et al.. (2012). Recommendations for the treatment of ulcerative colitis with infliximab: A gastroenterology expert group consensus. Journal of Crohn s and Colitis. 6(2). 248–258. 32 indexed citations

18.

Muise, Aleixo M., Thomas D. Walters, Eytan Wine, et al.. (2007). Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis. Current Biology. 17(14). 1212–1218. 50 indexed citations

19.

Aiges, Harvey, et al.. (1980). Short stature in early onset Crohn's disease: more common than meets the eye.. Pediatric Research. 14. 1 indexed citations

20.

Nishi, Yoshihiro, et al.. (1980). Zinc status and its relation to growth retardation in children with chronic inflammatory bowel disease. American Journal of Clinical Nutrition. 33(12). 2613–2621. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact